Our Work
Latham & Watkins in Ourvita’s €170 Million Private Placement
February 12, 2025
A cross-border team represented the initial purchasers in the offering.
Ourvita, also known as Farmaceutici Procemsa S.p.A. Società Benefit, a company active in the development and production of pharmaceutical specialties, has announced that it has successfully priced an offering of €170 million aggregate principal amount by way of a private placement.
Latham & Watkins represented the initial purchasers in the offering with a team led by partners Marcello Bragliani, Fergus Wheeler, and Alessia De Coppi, with associates Medha Vikram, Davide Camasi, Wei Jing Pamela Ng, and Nicolle Odutoye. Advice on capital markets matters was provided by partner Matthew Schneider, with associates Marco Bonasso and Izabela Prager; and on tax matters by counsel Blanca Vàzquez de Castro.